{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:41:18Z","timestamp":1772131278657,"version":"3.50.1"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["R01HL128492-05S1"],"award-info":[{"award-number":["R01HL128492-05S1"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","award":["ISR005923"],"award-info":[{"award-number":["ISR005923"]}],"id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000088","name":"Manning Fund","doi-asserted-by":"publisher","award":["MC10"],"award-info":[{"award-number":["MC10"]}],"id":[{"id":"10.13039\/501100000088","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI145108"],"award-info":[{"award-number":["R01AI145108"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P01 AI116501"],"award-info":[{"award-number":["P01 AI116501"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Adenosine inhibits the activation of most immune cells and platelets. Selective adenosine A2A receptor (A2AR) agonists such as regadenoson (RA) reduce inflammation in most tissues, including lungs injured by hypoxia, ischemia, transplantation, or sickle cell anemia, principally by suppressing the activation of invariant natural killer T (iNKT) cells. The anti-inflammatory effects of RA are magnified in injured tissues due to induction in immune cells of A2ARs and ecto-enzymes CD39 and CD73 that convert ATP to adenosine in the extracellular space. Here we describe the results of a five patient study designed to evaluate RA safety and to seek evidence of reduced cytokine storm in hospitalized COVID-19 patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and findings<\/jats:title>\n<jats:p>Five COVID-19 patients requiring supplemental oxygen but not intubation (WHO stages 4\u20135) were infused IV with a loading RA dose of 5 \u03bcg\/kg\/h for 0.5 h followed by a maintenance dose of 1.44 \u03bcg\/kg\/h for 6 hours, Vital signs and arterial oxygen saturation were recorded, and blood samples were collected before, during and after RA infusion for analysis of CRP, D-dimer, circulating iNKT cell activation state and plasma levels of 13 proinflammatory cytokines. RA was devoid of serious side effects, and within 24 hours from the start of infusion was associated with increased oxygen saturation (93.8 \u00b1 0.58 vs 96.6 \u00b1 1.08%, P&lt;0.05), decreased D-dimer (754 \u00b1 17 vs 518 \u00b1 98 ng\/ml, P&lt;0.05), and a trend toward decreased CRP (3.80 \u00b1 1.40 vs 1.98 \u00b1 0.74 mg\/dL, P = 0.075). Circulating iNKT cells, but not conventional T cells, were highly activated in COVID-19 patients (65% vs 5% CD69+). RA infusion for 30 minutes reduced iNKT cell activation by 50% (P&lt;0.01). RA infusion for 30 minutes did not influence plasma cytokines, but infusion for 4.5 or 24 hours reduced levels of 11 of 13 proinflammatory cytokines. In separate mouse studies, subcutaneous RA infusion from Alzet minipumps at 1.44 \u03bcg\/kg\/h increased 10-day survival of SARS-CoV-2-infected K18-hACE2 mice from 10 to 40% (P&lt;0.001).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Infused RA is safe and produces rapid anti-inflammatory effects mediated by A2A adenosine receptors on iNKT cells and possibly in part by A2ARs on other immune cells and platelets. We speculate that iNKT cells are activated by release of injury-induced glycolipid antigens and\/or alarmins such as IL-33 derived from virally infected type II epithelial cells which in turn activate iNKT cells and secondarily other immune cells. Adenosine released from hypoxic tissues, or RA infused as an anti-inflammatory agent decrease proinflammatory cytokines and may be useful for treating cytokine storm in patients with Covid-19 or other inflammatory lung diseases or trauma.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0288920","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T17:27:08Z","timestamp":1691774828000},"page":"e0288920","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Regadenoson for the treatment of COVID-19: A five case clinical series and mouse studies"],"prefix":"10.1371","volume":"18","author":[{"given":"Joseph","family":"Rabin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunge","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezzat","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manal","family":"Al-Suqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Fleischmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0459-2336","authenticated-orcid":true,"given":"Mark R.","family":"Conaway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara J.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2229-3479","authenticated-orcid":true,"given":"Preeti","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth L.","family":"Brayman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Krupnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Linden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9921-0598","authenticated-orcid":true,"given":"Christine L.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"issue":"13","key":"pone.0288920.ref001","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention.","volume":"323","author":"Z Wu","year":"2020","journal-title":"JAMA"},{"key":"pone.0288920.ref002","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-0716-0211-9_15","article-title":"Evaluation of Activation and Inflammatory Activity of Myeloid Cells During Pathogenic Human Coronavirus Infection.","volume":"2099","author":"R Channappanavar","year":"2020","journal-title":"Methods Mol Biol"},{"issue":"2","key":"pone.0288920.ref003","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice","volume":"19","author":"R Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"1","key":"pone.0288920.ref004","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s13054-020-03022-1","article-title":"Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis.","volume":"24","author":"N Potere","year":"2020","journal-title":"Crit Care."},{"issue":"1","key":"pone.0288920.ref005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12967-017-1284-7","article-title":"Glucocorticoid attenuates acute lung injury through induction of type 2 macrophage.","volume":"15","author":"GW Tu","year":"2017","journal-title":"J Transl Med."},{"issue":"2","key":"pone.0288920.ref006","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jaci.2020.11.006","article-title":"Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study","volume":"147","author":"G Bozzi","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"17","key":"pone.0288920.ref007","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18179149","article-title":"Systematic Review and Meta-Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic.","volume":"18","author":"N Mahroum","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"pone.0288920.ref008","doi-asserted-by":"crossref","DOI":"10.3390\/cells11020306","article-title":"Janus Kinase Signaling Pathway and Its Role in COVID-19 Inflammatory, Vascular, and Thrombotic Manifestations.","volume":"11","author":"JD Ravid","year":"2022","journal-title":"Cells"},{"issue":"10","key":"pone.0288920.ref009","doi-asserted-by":"crossref","first-page":"e0239692","DOI":"10.1371\/journal.pone.0239692","article-title":"Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia.","volume":"15","author":"P Correale","year":"2020","journal-title":"PLoS One."},{"issue":"4 Pt 1","key":"pone.0288920.ref010","doi-asserted-by":"crossref","first-page":"C799","DOI":"10.1152\/ajpcell.1989.256.4.C799","article-title":"Turnover of adenosine in plasma of human and dog blood","volume":"256","author":"GH Moser","year":"1989","journal-title":"Am J Physiol"},{"issue":"4","key":"pone.0288920.ref011","doi-asserted-by":"crossref","first-page":"240","DOI":"10.15420\/aer.2019.05","article-title":"Unmasking Adenosine: The Purinergic Signalling Molecule Critical to Arrhythmia Pathophysiology and Management.","volume":"8","author":"GD Matthews","year":"2020","journal-title":"Arrhythm Electrophysiol Rev."},{"issue":"29","key":"pone.0288920.ref012","doi-asserted-by":"crossref","first-page":"18493","DOI":"10.1039\/D2RA02373C","article-title":"The NKT cell TCR repertoire can accommodate structural modifications to the lipid and orientation of the terminal carbohydrate of iGb3.","volume":"12","author":"G Cameron","year":"2022","journal-title":"RSC Adv."},{"key":"pone.0288920.ref013","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.3389\/fimmu.2018.02308","article-title":"The Impact of Invariant NKT Cells in Sterile Inflammation: The Possible Contribution of the Alarmin\/Cytokine IL-33.","volume":"9","author":"MH Ferhat","year":"2018","journal-title":"Front Immunol."},{"issue":"17","key":"pone.0288920.ref014","article-title":"Induction of antiinflammatory purinergic signaling in activated human iNKT cells.","volume":"3","author":"JC Yu","year":"2018","journal-title":"JCI Insight."},{"issue":"3","key":"pone.0288920.ref015","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/eji.201646343","article-title":"mTORC2 regulates multiple aspects of NKT-cell development and function","volume":"47","author":"T Sklarz","year":"2017","journal-title":"Eur J Immunol"},{"issue":"3","key":"pone.0288920.ref016","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2009-02-205492","article-title":"NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines","volume":"114","author":"KL Wallace","year":"2009","journal-title":"Blood"},{"issue":"12","key":"pone.0288920.ref017","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200872","article-title":"Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients","volume":"217","author":"Y Jouan","year":"2020","journal-title":"J Exp Med"},{"issue":"3","key":"pone.0288920.ref018","doi-asserted-by":"crossref","first-page":"H1055","DOI":"10.1152\/ajpheart.00651.2020","article-title":"Pannexin 1 channels control the hemodynamic response to hypoxia by regulating O2-sensitive extracellular ATP in blood","volume":"320","author":"BS Kirby","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7317","key":"pone.0288920.ref019","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nature09413","article-title":"Pannexin 1 channels mediate \u2019find-me\u2019 signal release and membrane permeability during apoptosis.","volume":"467","author":"FB Chekeni","year":"2010","journal-title":"Nature"},{"issue":"3","key":"pone.0288920.ref020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nri.2016.4","article-title":"Purinergic regulation of the immune system","volume":"16","author":"C Cekic","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"pone.0288920.ref021","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1172\/JCI0215337","article-title":"Ecto-5\u2019-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia.","volume":"110","author":"K Synnestvedt","year":"2002","journal-title":"J Clin Invest"},{"issue":"1","key":"pone.0288920.ref022","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1182\/blood-2008-06-165746","article-title":"Central role of Sp1-regulated CD39 in hypoxia\/ischemia protection","volume":"113","author":"HK Eltzschig","year":"2009","journal-title":"Blood"},{"issue":"Pt 3","key":"pone.0288920.ref023","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1042\/BJ20050888","article-title":"Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction.","volume":"391","author":"LJ Murphree","year":"2005","journal-title":"Biochem J"},{"issue":"2","key":"pone.0288920.ref024","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.molimm.2014.10.012","article-title":"Adenosine A2A receptor, a potential valuable target for controlling reoxygenated DCs-triggered inflammation","volume":"63","author":"C Liu","year":"2015","journal-title":"Mol Immunol"},{"issue":"1","key":"pone.0288920.ref025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1189\/jlb.0603300","article-title":"Activation of A2A adenosine receptors inhibits expression of alpha 4\/beta 1 integrin (very late antigen-4) on stimulated human neutrophils.","volume":"75","author":"GW Sullivan","year":"2004","journal-title":"J Leukoc Biol"},{"issue":"7","key":"pone.0288920.ref026","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1055\/s-0039-1688788","article-title":"Adenosine and Forskolin Inhibit Platelet Aggregation by Collagen but not the Proximal Signalling Events","volume":"119","author":"JC Clark","year":"2019","journal-title":"Thromb Haemost"},{"key":"pone.0288920.ref027","first-page":"312","article-title":"Sickle cell disease (SCD), iNKT cells, and regadenoson infusion.","volume":"123","author":"DG Nathan","year":"2012","journal-title":"Trans Am Clin Climatol Assoc."},{"issue":"6","key":"pone.0288920.ref028","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.healun.2020.02.003","article-title":"Adenosine A2A receptor agonist (regadenoson) in human lung transplantation.","volume":"39","author":"CL Lau","year":"2020","journal-title":"J Heart Lung Transplant."},{"issue":"2","key":"pone.0288920.ref029","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/JVI.02012-06","article-title":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus","volume":"81","author":"PB McCray","year":"2007","journal-title":"J Virol"},{"issue":"3","key":"pone.0288920.ref030","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.4269\/ajtmh.20-0762","article-title":"Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection","volume":"103","author":"GB Moreau","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"pone.0288920.ref031","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","article-title":"SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function","volume":"21","author":"ES Winkler","year":"2020","journal-title":"Nat Immunol"},{"issue":"17","key":"pone.0288920.ref032","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1182\/blood-2012-11-465963","article-title":"Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson","volume":"121","author":"JJ Field","year":"2013","journal-title":"Blood"},{"issue":"3","key":"pone.0288920.ref033","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s12350-016-0734-6","article-title":"Safety of regadenoson stress testing in patients with pulmonary hypertension","volume":"25","author":"VM Moles","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"pone.0288920.ref034","doi-asserted-by":"crossref","first-page":"108849","DOI":"10.1016\/j.clim.2021.108849","article-title":"A hitchhiker\u2019s guide through the COVID-19 galaxy","volume":"232","author":"S Felsenstein","year":"2021","journal-title":"Clin Immunol"},{"issue":"5","key":"pone.0288920.ref035","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"G Chen","year":"2020","journal-title":"J Clin Invest"},{"issue":"6","key":"pone.0288920.ref036","doi-asserted-by":"crossref","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.","volume":"19","author":"D McGonagle","year":"2020","journal-title":"Autoimmun Rev."},{"key":"pone.0288920.ref037","doi-asserted-by":"crossref","first-page":"749569","DOI":"10.3389\/fmed.2021.749569","article-title":"IL 33 Correlates With COVID-19 Severity, Radiographic and Clinical Finding.","volume":"8","author":"SS Markovic","year":"2021","journal-title":"Front Med (Lausanne)."},{"issue":"1","key":"pone.0288920.ref038","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.chom.2020.05.020","article-title":"A Mouse Model of SARS-CoV-2 Infection and Pathogenesis.","volume":"28","author":"SH Sun","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"20","key":"pone.0288920.ref039","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1182\/bloodadvances.2017009613","article-title":"Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease","volume":"1","author":"JJ Field","year":"2017","journal-title":"Blood Adv"},{"issue":"12","key":"pone.0288920.ref040","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1084\/jem.20061097","article-title":"Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation","volume":"203","author":"CM Lappas","year":"2006","journal-title":"J Exp Med"},{"issue":"12","key":"pone.0288920.ref041","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1097\/TP.0000000000000830","article-title":"Ex Vivo Perfusion With Adenosine A2A Receptor Agonist Enhances Rehabilitation of Murine Donor Lungs After Circulatory Death","volume":"99","author":"ML Stone","year":"2015","journal-title":"Transplantation"},{"issue":"10","key":"pone.0288920.ref042","doi-asserted-by":"crossref","first-page":"e74664","DOI":"10.1371\/journal.pone.0074664","article-title":"NF-kappaB is activated in CD4+ iNKT cells by sickle cell disease and mediates rapid induction of adenosine A2A receptors.","volume":"8","author":"G Lin","year":"2013","journal-title":"PLoS One."},{"issue":"23","key":"pone.0288920.ref043","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1182\/blood-2010-06-290643","article-title":"Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease","volume":"116","author":"KL Wallace","year":"2010","journal-title":"Blood"},{"issue":"12","key":"pone.0288920.ref044","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1161\/ATVBAHA.110.211615","article-title":"P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease","volume":"30","author":"R Polanowska-Grabowska","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"pone.0288920.ref045","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/17474086.2020.1831383","article-title":"D-dimer level in COVID-19 infection: a systematic review.","volume":"13","author":"M Rostami","year":"2020","journal-title":"Expert Rev Hematol"},{"issue":"10229","key":"pone.0288920.ref046","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"F Zhou","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"pone.0288920.ref047","doi-asserted-by":"crossref","first-page":"E216","DOI":"10.1148\/radiol.2020201629","article-title":"Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands.","volume":"297","author":"M Oudkerk","year":"2020","journal-title":"Radiology"},{"key":"pone.0288920.ref048","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"FA Klok","year":"2020","journal-title":"Thromb Res"},{"issue":"2","key":"pone.0288920.ref049","doi-asserted-by":"crossref","first-page":"e0171067","DOI":"10.1371\/journal.pone.0171067","article-title":"NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease.","volume":"12","author":"JJ Field","year":"2017","journal-title":"PLoS One."},{"issue":"2","key":"pone.0288920.ref050","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/eji.201444760","article-title":"Invariant natural killer T cells in lupus patients promote IgG and IgG autoantibody production","volume":"45","author":"L Shen","year":"2015","journal-title":"Eur J Immunol"},{"issue":"2","key":"pone.0288920.ref051","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.4049\/jimmunol.174.2.1073","article-title":"A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells","volume":"174","author":"CM Lappas","year":"2005","journal-title":"J Immunol"},{"issue":"14","key":"pone.0288920.ref052","doi-asserted-by":"crossref","first-page":"11303","DOI":"10.1074\/jbc.M111.323378","article-title":"Pannexin 1, an ATP release channel, is activated by caspase cleavage of its pore-associated C-terminal autoinhibitory region","volume":"287","author":"JK Sandilos","year":"2012","journal-title":"J Biol Chem"},{"key":"pone.0288920.ref053","doi-asserted-by":"crossref","first-page":"676577","DOI":"10.3389\/fphar.2021.676577","article-title":"Case Report: Can Inhaled Adenosine Attenuate COVID-19?","volume":"12","author":"BD Spiess","year":"2021","journal-title":"Front Pharmacol."},{"issue":"3","key":"pone.0288920.ref054","first-page":"287","article-title":"Adenosine: novel antiarrhythmic therapy for supraventricular tachycardia.","volume":"60","author":"JJ Nagelhout","year":"1992","journal-title":"AANA J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0288920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T17:27:48Z","timestamp":1691774868000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0288920"}},"subtitle":[],"editor":[{"given":"Emily","family":"Chenette","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":54,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0288920","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]}}}